EXPERIENCE IN TREATING BACTERIAL VAGINOSIS ASSOCIATED WITH VULVOVAGINAL CANDIDIASIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To investigate the efficacy of clindacin B prolong used to treat bacterial vaginosis (BV) concurrent with vulvovaginal candidiasis in nonpregnant reproductive-aged women. Subjects and methods. The investigation enrolled 30 patients aged 18 to 50years (mean age, 27.9±1.6 years) with BV concurrent with vulvovaginal candidiasis. After the disease was verified, all the patients received antibacterial therapy with clindacin B prolong at an intravaginal dose of 5.0 g overnight for 3 days. Results. Most of the women had a history of gynecological infectious diseases. The main complaints of the patients were white or gray vaginal discharge often with unpleasant odor. The vaginal pH value rose above 4.5 in all the cases. A total of 74 strains of strict anaerobic and aerobic microorganisms were isolated. 28 (93.3%) patients achieved clinical and etiological cure after treatment. Conclusion. The clinical efficacy of clindacin B prolong used to treat BV concurrent with vulvovaginal candidiasis in nonpregnant reproductive-aged women was 93.3%.

Full Text

Restricted Access

About the authors

Tatyana V. Zakharova

PhD, Associate Professor of the Department of Obstetrics Gynecology, Tula State University 300600, Russia, Tula, Lenina pr. 92

Valery G. Volkov

Email: Valvol@Yandex.ru
MD, Head of the Department of Obstetrics and Gynecology, Tula State University 300600, Russia, Tula, Lenina pr. 92

References

  1. Анкирская А.С., Муравьёва В.В. Интегральная оценка состояния микробиоты влагалища. Диагностика оппортунистических вагинитов (медицинская технология). М.; 2011. 21с. [Ankirskaya A.S., Muravyova V.V. Integral evaluation of the vaginal microbiota. Diagnosis of opportunistic infections (medical technology). Moscow; 2011. 21р. (in Russian)]
  2. Sobel J.D., Reichman O., Misra D., Yoo W. Prognosis and treatment of desquamative inflammatory vaginitis. Obstet. Gynecol. 2011; 117(4): 850-5.
  3. Захарова Т.В. Бактериальный вагиноз и бактериальный вагинит: клинико-микробиологические варианты течения. Вестник новых медицинских технологий. 2008; 15(1): 199-200. [Zakharova T.V. Bacterial vaginosis and bacterial vaginitis: clinical and microbiological course options. Vestnik novyh meditsinskih tehnologiy. 2008; 15(1): 199-200. (in Russian)]
  4. Волков В.Г., Бадаева А.А. Воспалительные изменения в последах у беременных с бактериальным вагинозом. Вестник Российского университета дружбы народов. Серия: Медицина. 2012; 5: 113-6. [Volkov V.G., Badaeva A.A. Inflammatory changes in the placenta in pregnant women with bacterial vaginosis. Bulletin of Peoples’ Friendship University of Russia. Series: Medicine”. 2012; 5: 113-6. (in Russian)]
  5. Олина А.А. Эпидемиологические и микробиологические аспекты неспецифических инфекционных заболеваний влагалища. Уральский медицинский журнал. 2008; 8: 160-3. [Olina A.A. Epidemiological and microbiological aspects of non-infectious diseases of the vagina. Ural Medical Journal. 2008; 8: 160-3. (in Russian)]
  6. Российское общество акушеров-гинекологов. Диагностика и лечение заболеваний, сопровождающихся патологическими выделениями из половых путей женщин: клинические рекомендации. М.: ГЭОТАР-Медиа; 2013. 47с. [Russian Society of Obstetricians and Gynecologists. Diagnosis and treatment of diseases characterized by pathological vaginal discharge: clinical recommendations. Мoscow: GEOTAR-Media. 2013; 47p. (in Russian)]
  7. Байрамова Г.Р., Прилепская В.Н., Цаллагова Е.В. Оценка эффективности и безопасности применения препарата «Клиндацин» в терапии больных с бактериальным вагинозом. Гинекология. 2006; 8(5): 14-6. [Bayramova G.R., Prilepskaya V.N., Tsallagova E.V. Evaluation of the effectiveness and safety of the antibiotic «Klindacin» in the therapy of patients with bacterial vaginosis. Ginekologiya. 2006; 8(5): 14-6. (in Russian)]
  8. Захарова Т.В., Волков В.Г., Лисицына Т.В. Современные подходы к лечению бактериального вагиноза. Акушерство и гинекология. 2005; 1: 40-2. [Zakharova T.V., Volkov V.G., Lisicina T.V. Modern approaches to treatment of bacterial vaginosis. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2005; (1): 40-2. (in Russian)]
  9. Федеральные клинические рекомендации по ведению больных урогенитальным кандидозом. М.; 2015. Available at: http://www.cnikvi.ru/ docs/clinic_recs/infektsii-peredavaemye-polovym-putem/ [Federal clinical recommendations on the management of urogenital candidiasis. Мoscow; 2015. http://www.cnikvi.ru/docs/clinic_recs/infektsii-peredavaemye-polovym-putem/ (in Russian)]
  10. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 1983; 74(1): 14-22.
  11. Nugent R.P., Krohn М.А., Hilfier S.L. Reliability of diagnosing bacterial vaginosis is improved by standardized method of gram stain interpretation. J. Clin. Microbiol. 1991; 29(2): 297-301.
  12. Савичева А.М., Шипицына Е.В., Воробьева Н.Е. Инфекционные заболевания влагалища и современные подходы к их диагностике и лечению. Акушерство и гинекология. 2016; 2: 120-6. [Savicheva A.M., Shipitsyna E.V., Vorobyeva N.E. Vaginal infectious diseases and current approaches to their diagnosis and treatment. Akusherstvo i Ginekologiya/ Obstetrics and Gynecology. 2016; (2): 120-6. (in Russian)]

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies